$11.50 -0.45 (%) Achillion Pharmaceuticals Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Momentum Stocks Showing Weakness

    Benzinga | Sep. 15, 2014 | 17:33PM EST
  2. Midday Losers From September 15 - Tesla Motors Inc, Digital Ally, Inc. And More

    Benzinga | Sep. 15, 2014 | 12:56PM EST
  3. Morning Market Losers

    Benzinga | Sep. 15, 2014 | 09:48AM EST
  4. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 15, 2014 | 08:15AM EST
  5. Morning Market Losers

    Benzinga | Sep. 12, 2014 | 09:45AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 12, 2014 | 08:06AM EST
  7. Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline

    Benzinga | Sep. 5, 2014 | 12:36PM EST
  8. Markets Edge Lower; Zumiez Issues Weak Outlook

    Benzinga | Sep. 5, 2014 | 10:21AM EST
  9. Top 5 Performing Biotech Stocks Of 2014

    Benzinga | Sep. 3, 2014 | 12:08PM EST
  10. Morning Market Movers

    Benzinga | Sep. 3, 2014 | 09:43AM EST
  11. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 3, 2014 | 08:04AM EST
  12. Morning Market Movers

    Benzinga | Sep. 2, 2014 | 09:46AM EST
  13. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 2, 2014 | 08:07AM EST
  14. Four biotech takeover targets?

    IBD | Aug. 29, 2014 | 18:58PM EST
  15. 4 Biotechs That Might Be Bought Soon

    IBD | Aug. 29, 2014 | 11:53AM EST
  16. Deutsche Bank Sees Achillion, Arrowhead As Potential Takeover Targets

    Benzinga | Aug. 26, 2014 | 13:37PM EST
  17. Morning Market Movers

    Benzinga | Aug. 26, 2014 | 09:38AM EST
  18. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 26, 2014 | 08:11AM EST
  19. Benzinga's M&A Chatter for Monday August 25, 2014

    Benzinga | Aug. 25, 2014 | 19:37PM EST
  20. Achillion Shares Spike Higher, Near $11 As UBS Analyst Sees Possibility Of M&A

    Benzinga | Aug. 25, 2014 | 15:04PM EST
  21. Weekly CEO Sells Highlight: Achillion Pharmaceutical Inc, Protective Life Corp, Host Hotels ...

    GuruFocus | Aug. 25, 2014 | 02:25AM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Aug. 22, 2014 | 08:23AM EST
  23. ACHILLION PHARMA

    IBD | Aug. 19, 2014 | 18:47PM EST
  24. UPDATE: Achillion Has Received US Patent for ACH-3102, Structurally-Related NS5A Inhibitors

    Benzinga | Aug. 19, 2014 | 16:06PM EST
  25. Achillion Pharmaceuticals

    IBD | Aug. 18, 2014 | 18:40PM EST
  26. Achillion Pharmaceuticals Up On Buyout Rumors

    IBD | Aug. 18, 2014 | 13:52PM EST
  27. Dow Surges 175 Points; Fabrinet Shares Slide

    Benzinga | Aug. 18, 2014 | 13:41PM EST
  28. Markets Open Higher; Dollar General Offers $9.7 Billon To Buy Family Dollar

    Benzinga | Aug. 18, 2014 | 11:25AM EST
  29. Morning Market Movers

    Benzinga | Aug. 18, 2014 | 09:45AM EST
  30. Deutsche Bank Raises Achillion Price Target 183%

    Benzinga | Aug. 18, 2014 | 08:28AM EST
  31. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 18, 2014 | 08:15AM EST
  32. Gilead Wins Sovaldi Ruling

    IBD | Aug. 15, 2014 | 19:17PM EST
  33. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD | Aug. 15, 2014 | 18:10PM EST
  34. Markets Close The Week On Negative Note As Ukraine Worries Mount

    Benzinga | Aug. 15, 2014 | 17:01PM EST
  35. U.S. Stocks Turn Lower; Dillard's Shares Slide On Downbeat Earnings

    Benzinga | Aug. 15, 2014 | 13:23PM EST
  36. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD | Aug. 15, 2014 | 12:23PM EST
  37. Markets Gain; J.C. Penney Posts Narrower-Than-Expected Q2 Loss

    Benzinga | Aug. 15, 2014 | 11:23AM EST
  38. Stocks Hitting 52-Week Highs

    Benzinga | Aug. 15, 2014 | 10:24AM EST
  39. Morning Market Movers

    Benzinga | Aug. 15, 2014 | 09:40AM EST
  40. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 15, 2014 | 08:17AM EST
  41. Morning Market Movers

    Benzinga | Aug. 11, 2014 | 09:45AM EST
  42. Benzinga's Top Upgrades

    Benzinga | Aug. 11, 2014 | 08:54AM EST
  43. Piper Jaffray Upgrades Achillion Pharmaceuticals To Overweight

    Benzinga | Aug. 11, 2014 | 08:19AM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 11, 2014 | 08:05AM EST
  45. Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline

    Benzinga | Jul. 3, 2014 | 09:39AM EST
  46. Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly

    Benzinga | Jun. 27, 2014 | 15:49PM EST
  47. Achillion

    IBD | Jun. 20, 2014 | 18:38PM EST
  48. Achillion Could Win Idenix's Mystery Suitor: Analyst

    IBD | Jun. 20, 2014 | 12:44PM EST
  49. Baird Comments On Achillion's Bullish Share Action

    Benzinga | Jun. 20, 2014 | 12:12PM EST
  50. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 18, 2014 | 08:12AM EST
Trading Center